Cardiovascular Protection: Major clinical trials like the LEADER trial for liraglutide have shown that GLP-1 RAs can significantly reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes
doi: 10.1089/ars.2012.5052 29 HernndezJ
There are several limitations to the conclusions that can be drawn from the studies with PF and FF
Injections require medical supervision
You may benefit from this therapy if you experience: Chronic fatigue or low energy Frequent illness or weakened immunity Brain fog or poor concentration Exposure to toxins, alcohol, or pollution Recovery from stress, illness, or travel How We Personalize Your Treatment At The Remedy Room, every therapy is customized to your unique biochemistry
It's not unusual for patients to text me the next morning saying they slept better than they have in months or that their usual afternoon brain fog never showed up